Clinical Trials Logo

Macular Holes clinical trials

View clinical trials related to Macular Holes.

Filter by:

NCT ID: NCT05860985 Recruiting - Retinal Detachment Clinical Trials

Zeiss RESIGHT Disposable Lenses Evaluation Study

RESIGHT
Start date: April 11, 2023
Phase: N/A
Study type: Interventional

To evaluate the intra-operative efficacy of a new intra-operative viewing device.

NCT ID: NCT05747144 Recruiting - Retinal Detachment Clinical Trials

Multimodal Imaging in Vitreo-retinal Surgery and Macular Dystrophies

MICAI
Start date: January 15, 2021
Phase:
Study type: Observational

The aim of the study is to identify morphological and functional biomarkers of post-operative recovery after vitreoretinal surgery, using decisional support systems (DSS), based on multimodal big-data analysis by means of machine learning techniques in daily clinical practice

NCT ID: NCT05517473 Completed - Macular Holes Clinical Trials

Efficacy and Safety Evaluation of MONOBLUE DUAL View and MONOBLUE ILM View Vital Stains

NewBlueDyes
Start date: July 5, 2022
Phase:
Study type: Observational

In this study, the investigators aim to collect data regarding the efficiency and safety of two dyes used intraoperatively in vitrectomy to stain intraocular tissues. These products have the necessary approvals to use during such operation,These are NOT experimental products.

NCT ID: NCT05396209 Recruiting - Macular Holes Clinical Trials

To Evaluate the Therapeutic Efficacy of Hydrated Amniotic Membrane in Promoting Closure of Refractory Macular Holes.

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

To compare anatomic and functional results, and to evaluate postoperatively the healing process in 3 different techniques for the closure of the refractory macular holes (MH).

NCT ID: NCT05269563 Completed - Macular Holes Clinical Trials

Double Flap Technique for Macular Hole

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Double flapping technique to close the macular hole.

NCT ID: NCT05223205 Completed - Macular Holes Clinical Trials

Optical Coherence Tomography Angiography Characteristics of Patients With Surgically Closed Full-thickness Idiopathic Macular Holes < 600 μm With Air Versus 10% SF6 Tamponade

Start date: July 6, 2020
Phase: N/A
Study type: Interventional

State of the art treatment for idiopathic macular holes consists of pars plana vitrectomy, internal limiting membrane staining with a blue colouring dye, internal limiting membrane peeling and filling of the vitrectomized space with a specific tamponade such as air and SF6. Air and SF6 have previously shown similar closure rates, although there was a trend towards lower closure rates in large diameter IMH (Idiopathic Macular Holes) using air. IMH with diameters < 600 μm are currently believed to have similar closure rates with air and SF6. The investigators want to assess possible effects of the used tamponade (air or SF6) on closure rates and perfusion parameters represented by OCTA (Optical coherence tomography angiography). IMH eyes with a minimum diameter > 600 μm will be excluded. Two idiopathic macular hole patient groups will therefore be formed: The first group (group 1) will receive air after vitrectomy and membrane peeling, the second group (group 2) will receive 10% SF6 (and 90% air) after vitrectomy and membrane peeling. After recruitment, patients will therefore be electronically randomized to one of the two groups. The groups will then be compared by the means of OCT (Optical coherence tomography) and OCTA. Note: The trial was registered retrospectively on Clinicaltrials.gov after start of recruitment.

NCT ID: NCT05191628 Terminated - Retinal Detachment Clinical Trials

Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole

Start date: June 10, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this open, multicenter trial is to assess the impact of the use of an amniotic membrane graft on the closure of macular hole-associated retinal detachment in patients with failed previous macular surgery.

NCT ID: NCT05171621 Completed - Epiretinal Membrane Clinical Trials

Measuring Subjective Quality of Vision and Metamorphopsia Before and After Epiretinal Membrane and Macular Hole Surgery

MQUEST
Start date: October 16, 2019
Phase:
Study type: Observational

Assessing metamorphopsia and quality of vision pre and post epiretinal and macular hole surgery

NCT ID: NCT05086588 Completed - Epiretinal Membrane Clinical Trials

Safety and Efficacy Evaluation of Two Different Brilliant Blue G Dyes as Staining Agent in Vitreo Retinal Surgery.

Start date: April 4, 2018
Phase:
Study type: Observational

This is a prospective, Open-label, comparative clinical study to asses two brilliant blue G dyes as staining agent in Vitro Retinal Surgery.

NCT ID: NCT05083650 Recruiting - Macular Holes Clinical Trials

Large Macular Hole Closure Rate With Amniotic Membrane Graft With and Without Limitorrhexis

Start date: March 10, 2021
Phase: N/A
Study type: Interventional

Patients with idiopathic macular holes (MHs) postoperative closure rates for large MHs (diameter > 550 μm) are disappointing and often require a second intervention, different techniques have been described with very variable success rates in different published studies, an efficient technique with good functional outcome has not been found.